Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.

This new technology could one day significantly expand the market for gene-editing biotechs.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

How can gene editing be used to improve plant health benefits? This is what a recent study published in Frontiers in Plant ...

Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements in genetic science.

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...

CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world's first approved CRISPR-based ...

Alabama A&M University students will gain hands-on experience in biotechnology research thanks to a $300,000 USDA grant.